Skip to main content
Displaying 85 - 96 of 100
Display:
12
24
48
Viral Hepatitis
6
Gilead Sciences: A new beginning in hepatitis delta - ILC 2021
View
Viral Hepatitis
6
Gilead Sciences: A new beginning in hepatitis delta - ILC 2021
View
Viral Hepatitis
5
Gilead Sciences: The Next Chapter in Viral Hepatitis - ILC 2021
View
Viral Hepatitis
5
Gilead Sciences: The Next Chapter in Viral Hepatitis - ILC 2021
View
Viral Hepatitis
5
Gilead Sciences: The Next Chapter in Viral Hepatitis - ILC 2021
View
Viral Hepatitis
5
Gilead Sciences: The Next Chapter in Viral Hepatitis - ILC 2021
View
Viral Hepatitis
5
Gilead Sciences: The Next Chapter in Viral Hepatitis - ILC 2021
View
Liver Tumours
6
Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021
View
Liver Tumours
6
Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021
View
Liver Tumours
6
Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021
View
Liver Tumours
6
Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021
View
Liver Tumours
6
Boston Scientific: SIRT: The versatility of current HCC treatment & the opportunities for the future - Digital Liver Cancer Summit 2021
View
Pagination
First page
« First
Previous page
‹ previous
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Current page
8
Page
9
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy